Bridge Biotherapeutics’ partnering strategy and growth by external innovation In this biotech networking event, two speakers from Bridge Biotherapeutics talked about the history of their…
Phialogics AG has announced the appointment of Prof. Dr. Erich Schlick as Chairman of its Board of Directors. Erich was introduced to Phialogics by BaseLaunch…
Our portfolio company, Phialogics - a preclinical stage company developing cell-type-specific immune checkpoint activators to prevent multi-organ failure in autoimmune diseases, closed a €600k pre-seed…
Engimmune Therapeutics, a Swiss biotech company developing novel T-cell receptor (TCR)-based therapeutics, has announced the appointment of Dr. Lars Nieba as Chief Executive Officer. Engimmune…
Alentis Therapeutics is a thriving clinical-stage biotech company in Basel, Switzerland, developing breakthrough treatments for organ fibrosis and CLDN1 positive tumors. The company, lead by…
Endometriosis is a painful and debilitating condition that affects one in every ten women. Despite being a common health issue, there are currently limited treatment…
What startups need to know about term sheets, legal due diligence and employee incentives Conducting legal due diligence and preparing and negotiating term sheets for…
Building biotech companies and raising venture capital financing In our latest event co-organized with Pureos, we had three extraordinary biotech founders (one of them who…